Inactive Instrument

OVES MEDI

Equities

OVN

AU000000OVN3

Oventus Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2020

February 21, 2021 at 04:32 pm EST

Oventus Medical Limited announced earnings results for the half year ended December 31, 2020. For the half year, the company announced total revenue was AUD 550,232 compared to AUD 188,406 a year ago. Net loss was AUD 4.678 million compared to AUD 5.126 million a year ago. Basic loss per share from continuing operations was AUD 0.0296 compared to AUD 0.0401 a year ago.

Latest news about OVES MEDI

Oventus Medical Delists from Australian Bourse	23-07-24	MT
Crystalaid Manufacture Pty Ltd. completed the acquisition of Oventus Manufacturing Pty Ltd from Oventus Medical Limited for AUD 0.01 million.	23-02-19	CI
Crystalaid Manufacture Pty Ltd. entered into an agreement to acquire Oventus Manufacturing Pty Ltd from Oventus Medical Limited for AUD 0.01 million	23-02-13	CI
Oventus Medical Limited Announces Resignation of Melvyn Bridges as Director	23-01-13	CI
Oventus Medical, Canadian Dental Clinical Partner Sign Exclusive Distribution Agreement	22-11-03	MT
Oventus Medical Limited, Oventus Manufacturing Pty Ltd and Oventus Crm Pty Ltd Appoints Melvyn Bridges as Director	22-10-11	CI
Oventus Medical Limited Announces Resignation of Chris Hart	22-06-08	CI
Oventus Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-27	CI
Transcript : Oventus Medical Limited - Special Call	22-01-31
Oventus Medical Limited Announces CEO Succession Plan	22-01-30	CI
Oventus Medical Limited Announces Executive Changes	22-01-30	CI
Transcript : Oventus Medical Limited - Shareholder/Analyst Call	21-11-17
Transcript : Oventus Medical Limited, Q1 2022 Earnings Call, Nov 04, 2021	21-11-03
Oventus Medical Ltd Provides an Update on Clinical Trial and Regulatory Matters	21-10-25	CI
Oventus Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-30	CI
Transcript : Oventus Medical Limited - Shareholder/Analyst Call	21-06-20
Oventus Medical Limited Appoints John Cox as President and Chief Operating Officer of the Company	21-06-03	CI
Oventus Medical Limited Announces Executive Changes	21-06-03	CI
Oventus Medical Ltd Signs New Virtual Lab in Lab Agreement with Sleep Metrics	21-04-21	CI
Oventus Medical : InHome Oxygen and Medical Equipment Enter Virtual Lab in Lab Agreement; Shares Jump 8%	21-03-29	MT
Oventus Medical Ltd Signs First New Contract Under Oventus' Marketing Agency Agreement	21-03-28	CI
Transcript : Oventus Medical Limited Presents at NWR Communications Virtual Resources Conference, Mar-18-2021 10:45 AM	21-03-17
Oventus Medical Limited Signs Agreements with Connect DME	21-03-17	CI
Oventus Medical Limited Signs Distribution Agreement with Circadian Australia	21-03-17	CI
Oventus Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-21	CI

Chart OVES MEDI

Duration

Period

More charts

Company Profile

Oventus Medical Limited is an Australia-based medical device company. The Company is commercializing a treatment platform for obstructive sleep apnea (OSA) and snoring. The Companyâs O2Vent devices are designed for any patient that is deemed appropriate for oral appliance therapy, but especially beneficial for the many people that suffer with nasal congestion, obstruction and mouth breathing. The Companyâs product offerings include Oventus O2Vent Optima, O2Vent Optima, the ExVent and O2Vent Optima Mini. The Oventus O2Vent Optima product range provides relief to people who suffer snoring or mild to moderate OSA, and those who are unable to tolerate continuous positive airway pressure (CPAP) therapy. Its O2Vent Optima is an oral appliance, which features an integrated airway, using its own airway technology to treat the upper airway. It provides an uninterrupted airflow during sleep, as well as when a patient experiences nasal obstruction.

Sector

More about the company